Why did you decide to pivot from enzyme manufacturing to biopharmaceuticals?
Replied byKiran Mazumdar-Shaw
Founder & Executive Chairperson at Biocon
Niche: Health & Wellness
Revenue: Approx. $172 Million/month
Location: Bengaluru, Karnataka, India
Started: 1978
I like to challenge myself and reinvent my business. Around 1996, I decided to apply our fermentation platforms to pharmaceuticals. We successfully produced statins, capturing a significant share of the global active pharmaceutical ingredient market, and then began targeting recombinant human insulin.
0
From the Full Interview
This answer is part of a full interview with Kiran Mazumdar-Shaw, Founder & Executive Chairperson at Biocon.
Share this Answer
Found this insight valuable? Share it with your network to help others learn from Kiran Mazumdar-Shaw's experience.
Cite This Answer
Use this answer in your research, article, or academic work
Related Answers
How did you make the transition from brewing to founding a biotechnology startup?
By Kiran Mazumdar-Shaw
Health & Wellness
Approx. $172 Million/mo
How has Chapter attracted investors from different political and professional backgrounds?
By Cobi Blumenfeld-Gantz
Health & Wellness
Approx. 8.3 Million/mo
Why did you move from medicine and research into entrepreneurship?
By Dr Emil Kendziorra
Health & Wellness
$50K-$250K/mo
What makes cryopreservation different from other longevity approaches?
By Dr Emil Kendziorra
Health & Wellness
$50K-$250K/mo
What makes Oscar Health different from traditional insurance companies?
By Mark Bertolin
Health & Wellness
$500M+/mo
How did your father's liberal worldviews shape your early career decisions?
By Kiran Mazumdar-Shaw
Health & Wellness
Approx. $172 Million/mo
What was your father's perspective on paying capitation fees to secure a college seat?
By Kiran Mazumdar-Shaw
Health & Wellness
Approx. $172 Million/mo